Follow ZDNET: Add us as a preferred source on Google. Netflix wasn't the first streaming platform, but it was the first to make video-on-demand mainstream. Fourteen years ago, as it phased out its ...

Tom Bowen is a senior editor who loves adventure games and RPGs. He's been playing video games for several decades now and writing about them professionally since 2020. Although he dabbles in news and ...

GameSpot may get a commission from retail offers. December 18: We checked for new Marvel Rivals codes and updated the Twitch Drops information. Marvel Rivals exploded into existence in late 2024 and ...

GameSpot may get a commission from retail offers. December 18, 2025: We checked for new codes for The Forge and removed any expired ones. The Forge is an exciting Roblox experience, which should be ...

Anthropic PBC, maker of the Claude family of artificial intelligence models, today introduced a feature in beta mode that lets developers delegate coding tasks to Claude Code directly inside the ...

The Italy Olympic torch relay for the 2026 Winter Games began Saturday in Rome, setting the flame on a cross-country journey through Italy two months before the Milan Cortina Olympics start. The torch ...

What are the new All Star Tower Defense X codes? You won't be pulling new units without them unless you're speedrunning death on a low-level stage. This long-in-development sequel to Roblox tower ...

Where Winds Meet has a pretty intricate character creator to play around with, but with great customization options comes great responsibility to not make Shrek. Alas, this mighty responsibility has ...

Looking for Grow a Garden codes? Plenty of Roblox experiences have codes, and Grow a Garden is no exception. Way back during the Lunar Glow Event, a code redemption system was added. Since then, ...

Want some codes for extra cash to spend on animations, styles, emotes, and more in Azure Latch? Or should that be Delay Latch? Anyway, we've got you covered. In this article, you'll find all the ...

Relay Therapeutics leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety and efficacy in advanced breast cancer. RLY-2608’s phase 1/2 trial data demonstrates higher response rates ...